Pituitary pars intermedia dysfunction (PPID) is a progressive chronic neurodegenerative disorder that we are still working to understand. But recently, our knowledge about equine endocrine disorders has expanded – thanks to independent researchers such as the Equine Endocrinology Group (EEG), as well as dedicated research contributed by Boehringer Ingelheim.

QUESTIONS? Please contact Boehringer Ingelheim Customer Care at 888-637-4251 or [email protected] Suspect PPID? Maybe you should.

QUESTIONS? Please contact Boehringer Ingelheim Customer Care at 888-637-4251 or [email protected] ©2025 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA.

QUESTIONS? Please contact Boehringer Ingelheim Customer Care at 888-637-4251 or [email protected] ©2025 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA.

QUESTIONS? Please contact oehringer Ingelheim Customer Care at 888-637-4251 or [email protected] ©2022 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA.

Introduction Measurement of adrenocorticotropic hormone (ACTH) has become the most common diagnostic method utilized for the diagnosis of pituitary pars intermedia dysfunction (PPID) in horses.

idppid.com

Page 4 Figure 2 – Clinical progression of PPID *Note: affected animals may have only one, several or many of the listed signs PRACTICE TIP: Increasing animal age and number of